Park Medi World IPO Allotment LIVE: Check allotment status on BSE, NSE, and Kfin Technologies; latest IPO GMP at ₹6

Kfin Technologies

1. Open Kfin Technologies website on your device.

2. In the ‘Select IPO’ dropdown, choose ‘Park Medi World Ltd’.

3. Enter your Demat Account Number, PAN, or IPO Application Number.

4. Click ‘Submit’ to check your IPO allotment status.

NSE

1. Go to the IPO allotment page on the NSE website: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

2. Click on ‘Equity & SME IPO bid details’.

3. From the ‘Select Symbol’ dropdown, choose ‘PARKHOSPS’.

4. Enter your application number and PAN.

5. Click ‘Submit’ to view your IPO allotment.

On BSE

Open the IPO allotment page on the BSE website - https://www.bseindia.com/static/investors/application_statuschecksystem.aspx

2. Choose the issue type to Equity.

3. From the IPO name dropdown, select Park Medi World Ltd.

4. Enter your IPO application number or PAN.

4. Click Search to check your share allotment status.

Anand Rathi has taken a positive view of the Park Medi World IPO, noting that the company’s valuation and growth plans align well with rising demand for quality healthcare. At the upper end of the price band, the company is valued at 32.8x FY25 P/E, implying a post-issue market capitalisation of ₹53,559 million.

The brokerage said the hospital chain aims to expand through a mix of organic growth and strategic acquisitions, while improving occupancy at existing centres and scaling operations at newer facilities. Investments in advanced equipment, technology, new clinical programs, and skilled medical professionals remain central to its strategy.

Anand Rathi stated, “Park Medi World aims to capture the growing demand for affordable, high-quality healthcare by strengthening its network and enhancing operational efficiency. With a strong focus on attracting experienced medical talent, the IPO appears fairly valued and is rated ‘Subscribe – Long Term’.”

Founded in 2011, New Delhi–based Park Medi World is a private healthcare chain with a strong presence across North India. The company operates 14 multi-super speciality hospitals under the ‘Park’ brand, with a combined capacity of 3,000 beds. Its network covers Haryana, Delhi, Punjab, and Rajasthan, offering more than 30 super speciality and speciality services.

The IPO is being managed by a team of book running lead managers (BRLMs) comprising Nuvama Wealth Management, CLSA India, DAM Capital Advisors, and Intensive Fiscal Services. KFin Technologies is serving as the registrar to the issue, overseeing the processing of applications, the allotment of shares, and the electronic credit of securities to successful bidders.

Refund initiations and credit of shares are expected by Tuesday, December 16. The shares of Park Medi World will be listed on both BSE and NSE on December 17, 2025.

The shares of Park Medi IPO is currently trading at a grey market premium (GMP) of ₹6.5. The indicated that the estimated listing price of Park Medi IPO is likely to be ₹168, which is 3.70% higher than the IPO price of ₹162.

Master Capital Services remains optimistic about the IPO. It noted that with the sector projected to grow from ₹6.9–7.0 trillion in FY2025 to ₹9.4–9.8 trillion by FY2028, Park Medi World is well positioned to capitalise on this expansion through its network of multi-super specialty hospitals, cutting-edge technology and patient-focused model. Backed by rising lifestyle diseases, an aging population and government schemes such as PMJAY, the company is expected to benefit from strong industry tailwinds. Master Capital believes these strengths make the IPO a solid long-term opportunity.

Of the fresh issue proceeds, Park Medi World plans to deploy ₹380 crore towards repayment of borrowings for the company and its subsidiaries. Another ₹60.50 crore is earmarked for establishing a new hospital and expanding both its own facilities and those of its subsidiary. A further ₹27.46 crore will be used for medical equipment purchases, with the balance allocated to general corporate purposes and potential inorganic opportunities yet to be identified.

Under the IPO structure, up to 50% of the issue is reserved for qualified institutional buyers, at least 35% for retail investors and no less than 15% for non-institutional investors.

Kfin Technologies

1. Open Kfin Technologies website on your device.

2. In the ‘Select IPO’ dropdown, choose ‘Park Medi World Ltd’.

3. Enter your Demat Account Number, PAN, or IPO Application Number.

4. Click ‘Submit’ to check your IPO allotment status.

NSE

1. Go to the IPO allotment page on the NSE website: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

2. Click on ‘Equity & SME IPO bid details’.

3. From the ‘Select Symbol’ dropdown, choose ‘PARKHOSPS’.

4. Enter your application number and PAN.

5. Click ‘Submit’ to view your IPO allotment.

On BSE

Open the IPO allotment page on the BSE website - https://www.bseindia.com/static/investors/application_statuschecksystem.aspx

2. Choose the issue type to Equity.

3. From the IPO name dropdown, select Park Medi World Ltd.

4. Enter your IPO application number or PAN.

4. Click Search to check your share allotment status.

According to data available on NSE, the IPO received an overall subscription of 8.52 times. The issue attracted bids for 338.83 million equity shares compared to the 41.82 million shares offered. On the last day of bidding, the Retail category was subscribed to 3.32 times, while Non-Institutional Investors (NIIs) showed strong interest by booking their quota 15.93 times. The Qualified Institutional Buyers (QIBs) segment was subscribed 12.07 times.

The shares of Park Medi IPO is currently trading at a premium of ₹6.5 in the grey market. The indicated that the estimated listing price of Park Medi IPO is likely to be ₹168.5, which is 4.01% higher than the IPO price of ₹162.